SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
525Very interesting Nigel, thanks.keokalani'nui-12/1/2004
524...Pursuant to the Subscription Agreement, CAT and AstraZeneca have each given cnigel bates-12/1/2004
523Interesting snippet from the recent results statement seems to indicate that glanigel bates-11/29/2004
522funny you should mention brussel sprouts-seems to be the only food my hedgehog dMadharry-11/24/2004
521Ditto. I've been bothered that there is no greater loss for ABT than what tkeokalani'nui-11/24/2004
520Nigel: >Would love to get to see the Abbott response.< I think Abbott wilfred hayes-11/24/2004
519<i>My instinct (and it's no more than that) is that at very least CATGnigel bates-11/24/2004
518Any British barristers here? I wonder if someone could walk us through how sometMadharry-11/23/2004
517I emailed them and got sent a bunch of documents a few hours later (with apologiBiomaven-11/23/2004
516If there is no basis in the original handshake for ABT's position, how can tkeokalani'nui-11/22/2004
515<i>Abbott says its dispute with Cambridge Antibody isn't unique in thenigel bates-11/22/2004
514<i>I'll email CAT IR tomorrow.</i> CAMBRIDGE, England, Nov. 22 nigel bates-11/22/2004
513Based on that reporting I am more optimistic than ever. Exactly the kind of bigkeokalani'nui-11/22/2004
512Abbott's Bid to Squeeze Royalties May Carry Wider Impact Outside Audit By keokalani'nui-11/22/2004
511Great, now there's going to be an Abbott exec. running HGSI - Message 20790nigel bates-11/22/2004
510Excerpts from the results, which were a bit too large to post entire: ...In Novnigel bates-11/22/2004
509Cambridge Antibody Technology and AstraZeneca Announce Major Strategic Alliance nigel bates-11/22/2004
508CAT fight over drug royalty pivotal for UK biotech Fri Nov 19, 2004 11:12 AM ET nigel bates-11/19/2004
507<i>SOBs. Hope ABT has its head handed to it.</i> Press Release Skeokalani'nui-11/10/2004
506My afternoon for kids' violin lesson... nice surprise to get back to. Seem nigel bates-11/9/2004
505Never cared for trabio. Now that it's washed out I'll be holding for thkeokalani'nui-11/9/2004
504I liquidated my position this am after the announcementMadharry-11/9/2004
503Not a good day for CAT; now Trabio fails: >>CAMBRIDGE, England, Nov. 9 /Ptuck-11/9/2004
502Abbott adds warnings to arthritis drug label WASHINGTON, Nov 8 (Reuters) - Abbnigel bates-11/9/2004
501Humira figures... <pre>The following is a summary of Abbott's third-qnigel bates-10/14/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News